◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Zeria Pharmaceutical Co., Ltd. (4559) Financial History

Name: Zeria Pharmaceutical Co., Ltd. (4559) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Zeria Pharmaceutical Co., Ltd. (4559) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tokyo, Japan with about 1,748 employees. Its market capitalization is roughly JPY 91 billion. In the fiscal year ended 2026-03-31, 4559 reported JPY 89.2B in revenue and JPY 8.5B in net income.

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

Interactive charts & full statements →

4559 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	JPY 89.2B	JPY 87.3B	JPY 75.7B	JPY 68.4B	—
Gross Profit	JPY 65.2B	JPY 64.0B	JPY 55.5B	JPY 49.5B	—
Operating Income (EBIT)	JPY 12.4B	JPY 12.2B	JPY 9.6B	JPY 9.0B	—
Net Income	JPY 8.5B	JPY 9.9B	JPY 7.7B	JPY 6.2B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4559 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 2.1B)	(JPY 2.0B)	(JPY 1.9B)	(JPY 1.6B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4559 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	JPY 179.7B	JPY 159.2B	JPY 150.5B	JPY 135.0B
Total Liabilities	JPY 71.1B	JPY 69.4B	JPY 70.7B	JPY 69.4B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4559 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

4547 · Kissei Pharmaceutical Co., Ltd. — $171 billion
4521 · Kaken Pharmaceutical Co., Ltd. — $151 billion
TEVA · Teva Pharmaceutical Industries Limited — ₪125 billion
4534 · Mochida Pharmaceutical Co., Ltd. — $114 billion
4569 · KYORIN Pharmaceutical Co., Ltd. — $64 billion
4886 · ASKA Pharmaceutical Holdings Co.,Ltd. — $58 billion
4554 · Fuji Pharma Co., Ltd. — $48 billion
2196 · Shanghai Fosun Pharmaceutical (Group) Co., Ltd. — $46 billion

← 4558 All “0-9” companies 4565 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.